Subcutaneous Administration of Monoclonal Antibodies: Pharmacology, Delivery, Immunogenicity, and Learnings From Applications to Clinical Development
Description
Subcutaneous (SC) administration of monoclonal antibodies (mAbs) can reduce treatment burden for patients and healthcare systems compared to intravenous (IV) infusion through shorter administration times, made possible by convenient, patient-centric
